REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
30/03/2026
Voltar para busca
Dado oficial do USPTO
APTORUM THERAPEUTICS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
APTORUM THERAPEUTICS
ST13
US500000087668718Classe
5, 10, 42, 44
Pedido
87668718
Registro
6303551
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
67
Atualização mais recente
31/03/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 10, 42, 44
Data de depósito
01/11/2017
Data de registro
30/03/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
30/03/2021
Última transação
31/03/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Código do desenho
4
Tipo de titular
99
Localização do titular
Hong Kong, KY
Examinador
DICKEY, ERICA
Unidade examinadora
M30
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Aptorum Group Limited
Aptorum Group Limited
Representantes
Sam Yip Idea Intellectual Limited
Classificação técnica
Classes Nice
Classe 5Classe 10Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations and traditional Chinese medicine for the diagnosisprevention and treatment of gastro-intestinal diseases and disorders; pharmaceutical preparations for the diagnosisprevention and treatment of diseases and disorders relating to women's healthgynecological diseases and disordersendometrial disease and disorders; pharmaceutical products and preparations and traditional Chinese medicine for the treatment of orthopedic injuries and conditions; pharmaceutical preparations and traditional Chinese medicine for the diagnosisprevention and treatment of ophthalmological diseasesconditions and disorders; pharmaceutical preparations and traditional Chinese medicine for the diagnosisprevention and treatment of neurological diseases and disorders; pharmaceutical preparations and traditional Chinese medicine for the diagnosisprevention and treatment of neurodegenerative diseases and disorders; pharmaceutical preparations and traditional Chinese medicine for the diagnosisprevention and treatment of peripheral nervous system diseases and disorders; pharmaceutical preparations and traditional Chinese medicine for the diagnosisprevention and treatment of cognitive deficiencies and neurodegenerative diseases and for the treatment of brain and spinal cord diseases or degenerative disorders and for improving neurological abilities
Classe 10
Surgical apparatus and instruments for use in the field of gastro-intestinal medicineorthopedics and ophthalmology; Medical apparatus and instrumentssurgical robotic apparatus and non-invasive detection tools in the nature of medical imaging devices for detecting brain plaques; medical and surgical apparatusinstruments and parts therefor for use in magnetic resonance imaging and other imaging-guided surgeryincluding markers for use in patient registration in the nature of procedures used in computer assisted surgeries and tracking the location of instruments within the patient's body during image guided surgeries; medical and surgical apparatusinstruments and parts therefor for use in minimum invasive surgery; medical apparatus for the treatment of neurodegenerative diseases; medical instruments and articlesanalytical apparatus for diagnosis of neurodegenerative diseases; analysis apparatus for medical purposesnon-invasive detection apparatus probes and imaging devices for use in the fields of neurology and neurobiology; diagnostic apparatus for medical purposesfor diagnosing plagues and images in brain for use in the fields of neurology and neurobiology; medical diagnostic apparatus for the detection of neurodegenerative diseases and conditions; surgicalmedical apparatus and instruments for the preventiontreatment and repair of neurodegenerative diseases and disorders; medical testing apparatus used for the treatment of cognitive deficienciesneurodegenerative diseases and for the treatment of brain and spinal cord diseases or degenerative disorders and for improving neurological abilities
Classe 42
Pre-clinical and clinical services for pharmaceutical and diagnostic test formulation researchpharmacological studiestoxicokinetic and pharmacokinetic studiestoxicity testsbioequivalence studiesstability testsclinical trialsclinical researchmedical research in the fields of gastro-intestinal medicinewomen's healthorthopedics and ophthalmology; conducting clinical trials for diagnostic tests and for pharmaceutical preparations in the fields of gastro-intestinal medicinewomen's healthorthopedics and ophthalmology; scientific and toxicology research services in the fields of gastro-intestinal medicinewomen's healthorthopedics and ophthalmology; biopharmaceutical research for development of targeted therapies for use in the treatment of gastrointestinal diseases and disordersdiseases and disorders relating to woman's healthorthopedics and orthopedic injuries and conditionsophthalmological diseasesconditions and disorders; providing medical testing services for research purposes and medical and scientific research information in the fields of gastro-intestinal medicinewomen's healthorthopedics and ophthalmology; pre- clinical and clinical services for formulation researchpharmacological studiestoxicokinetic and pharmacokinetic studiestoxicity testsbioequivalence studiesstability testsclinical trialsclinical researchmedical research in the field of neurodegenerative diseases; conducting clinical trials for diagnostic tests and for pharmaceutical preparations in the field of neurodegenerative diseases; scientific and toxicology research services in the field of neuroscience and neurodegenerative diseases; biopharmaceutical research for development of targeted therapies for use in the treatment of neurodegenerative diseases and disorders; providing medical testing services for research purposes and medical and scientific research information in the fields of degenerative and neurodegenerative diseases; consulting for pharmacology and medical toxicology in the fields of gastro-intestinal medicinewomen's healthorthopedics and ophthalmology; consulting for pharmacology and toxicology in the field of neurodegenerative diseases and disorders
Classe 44
Providing targetedindividualized treatment regimenstherapies or combination therapy for patients suffering from gastro-intestinal diseases and disordersdiseases and disorders relating to woman's healthorthopedics and orthopedic injuries and conditionsophthalmological diseasesconditions and disorders; medical testing for diagnostic or treatment purposes in the fields of gastro-intestinal medicinewomen's healthorthopedics and ophthalmology; providing targetedindividualized treatment regimenstherapies or combination therapy for patients suffering from neurodegenerative diseases and disorders; medical testing for diagnostic or treatment purposes in the field of neurodegenerative diseases and disorders
Publicações
Histórico de despachos e eventos da marca no USPTO.
67 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
30/03/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/01/2021
PUBO
PUBLISHED FOR OPPOSITION
12/01/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
23/12/2020
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/12/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
30/11/2020
OTHE
CASE RETURNED TO EXAMINATION
30/11/2020
IUCN
NOTICE OF ALLOWANCE CANCELLED
30/11/2020
EX1G
SOU EXTENSION 1 GRANTED
30/11/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/10/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/10/2020
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
06/10/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/10/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/10/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/10/2020
EXT1
SOU EXTENSION 1 FILED
10/06/2020
EEXT
SOU TEAS EXTENSION RECEIVED
10/06/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/06/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/05/2020
GNRT
NON-FINAL ACTION E-MAILED
07/05/2020
CNRT
NON-FINAL ACTION WRITTEN
07/05/2020
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
28/04/2020
ATRQ
ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
10/04/2020
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
10/04/2020
APET
ASSIGNED TO PETITION STAFF
10/04/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/03/2020
44EP
44(e) PETITION - RECEIVED
06/02/2020
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
06/02/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/12/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
15/10/2019
PUBO
PUBLISHED FOR OPPOSITION
15/10/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
25/09/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/09/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
06/09/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/09/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
06/09/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/09/2019
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
26/08/2019
GPRA
PRIORITY ACTION E-MAILED
26/08/2019
CPRA
PRIORITY ACTION WRITTEN
26/08/2019
NREV
NOTICE OF REVIVAL - E-MAILED
02/08/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/08/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/08/2019
ALIE
ASSIGNED TO LIE
02/08/2019
PGRR
PETITION GRANTED - RESPONSE RECEIVED
02/08/2019
APET
ASSIGNED TO PETITION STAFF
30/07/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/06/2019
PROA
TEAS PETITION TO REVIVE RECEIVED
08/06/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/12/2018
GNRT
NON-FINAL ACTION E-MAILED
07/12/2018
CNRT
NON-FINAL ACTION WRITTEN
07/12/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/11/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/11/2018
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
12/11/2018
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
05/09/2018
GNFR
FINAL REFUSAL E-MAILED
05/09/2018
CNFR
FINAL REFUSAL WRITTEN
05/09/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
15/08/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/08/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
14/08/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
14/02/2018
GNRT
NON-FINAL ACTION E-MAILED
14/02/2018
CNRT
NON-FINAL ACTION WRITTEN
14/02/2018
DOCK
ASSIGNED TO EXAMINER
12/02/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/11/2017
NWAP
NEW APPLICATION ENTERED
04/11/2017
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace APTORUM THERAPEUTICS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.